Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile InfectionSahil Khanna, Paul Feuerstadt, Maha Assi et al.|Drugs|2022Cited by 273
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in ChildrenMaribeth R. Nicholson, Stacy A. Kahn, Paul D. Mitchell et al.|Clinical Gastroenterology and Hepatology|2019Cited by 122
Reporting guideline for the use of Generative Artificial intelligence tools in MEdical Research: the GAMER StatementXufei Luo, Janne Estill, Akihiko Ozaki et al.|BMJ evidence-based medicine|2025Cited by 47
Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile InfectionSahil Khanna, Paul Feuerstadt, Maha Assi et al.|Drugs|2022Cited by 6